BETA — Beta Drugs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual balance sheet for Beta Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	53	104	173	192	286
Net Total Accounts Receivable
Net Total Receivables	354	382	531	714	923
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	560	680	970	1,277	1,779
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	403	393	507	581	592
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,072	1,175	1,579	1,984	2,541
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	367	333	490	630	847
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	501	489	655	755	970
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	571	686	923	1,229	1,571
Total Liabilities & Shareholders' Equity	1,072	1,175	1,579	1,984	2,541
Total Common Shares Outstanding